Hepatitis C virus RNA localization in human carotid plaques

Journal of Clinical Virology

Volumn 47, Issue 1, 2010, Pages 72-75

  Boddi, Maria ^a   Abbate, Rosanna ^b   Chellini, Benedetta ^a   Giusti, Betti ^b   Giannini, Carlo ^a   Pratesi, Giovanni ^a   Rossi, Luciana ^b   Pratesi, Carlo ^a   Gensini, Gian Franco ^a,c   Paperetti, Laura ^a   Zignego, Anna Linda ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Carotid atherosclerosis; Hepatitis C virus; Plaque infection

Indexed keywords

GENOMIC RNA;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CLINICAL ARTICLE; FEMALE; GENE SEQUENCE; HEPATITIS C VIRUS; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS LOAD;

AGED; AGED, 80 AND OVER; CAROTID STENOSIS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 72149090654     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.10.005     Document Type: Article

References (32)

1. Fabricant C.G., Fabricant J., Litrenta M.M., and Minick C.R. Virus-induced atherosclerosis. J Exp Med 148 (1978) 335-340
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
3. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., Kopp H., Victor A., et al. Impact of infectious burden on progression of carotid atherosclerosis. Stroke 33 (2002) 2581-2586
4. Prasad A., Zhu J., Halcox J.P., Waclawiw M.A., Epstein S.E., and Quyyumi A.A. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 106 (2002) 184-190
5. Kalayoglu M.V., Libby P., and Byrne G.I. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 288 (2002) 2724-2731
6. Gibson III F.C., and Genco C.A. Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs. Curr Pharm Des 13 (2007) 3665-3675
7. Hendrix M.G., Salimans M.M., van Boven C.P., and Bruggeman C.A. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 136 (1990) 23-28
8. Stoll G., and Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37 (2006) 1923-1932
9. Froberg M.K., Adams A., Seacotte N., Parker-Thornburg J., and Kolattukudy P. Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1. Circ Res 89 (2001) 1224-1230
10. Zignego A.L., and Craxi A. Extrahepatic manifestations of hepatitis C virus infection. Clin Liver Dis 12 (2008) 611-636 ix
11. Zignego A.L., Giannini C., Monti M., and Gragnani L. Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis 39 Suppl 1 (2007) S38-45
12. Pham T.N., MacParland S.A., Mulrooney P.M., Cooksley H., Naoumov N.V., and Michalak T.I. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78 (2004) 5867-5874
13. Radkowski M., Gallegos-Orozco J.F., Jablonska J., Colby T.V., Walewska-Zielecka B., Kubicka J., et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41 (2005) 106-114
14. Giannini C., Petrarca A., Monti M., Arena U., Caini P., Solazzo V., et al. Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia. Blood 111 (2008) 2943-2945
15. Agnello V., Abel G., Elfahal M., Knight G.B., and Zhang Q.X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 96 (1999) 12766-12771
16. Voisset C., Callens N., Blanchard E., Op De Beeck A., Dubuisson J., and Vu-Dac N. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem 280 (2005) 7793-7799
17. Peng Y.S., Chiang C.K., Hsu S.P., Pai M.F., Hung K.Y., and Kao J.H. Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients. Blood Purif 23 (2005) 106-112
18. Tardif K.D., Waris G., and Siddiqui A. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol 13 (2005) 159-163
19. Ishizaka N., Ishizaka Y., Takahashi E., Tooda E., Hashimoto H., Nagai R., et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 359 (2002) 133-135
20. Ishizaka Y., Ishizaka N., Takahashi E., Unuma T., Tooda E., Hashimoto H., et al. Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J 67 (2003) 26-30
21. Bilora F., Rinaldi R., Boccioletti V., Petrobelli F., and Girolami A. Chronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta. Gastroenterol Clin Biol 26 (2002) 1001-1004
22. Vassalle C., Masini S., Bianchi F., and Zucchelli G.C. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart 90 (2004) 565-566
23. Boddi M., Abbate R., Chellini B., Giusti B., Solazzo V., Soft F., et al. HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques. Dig Liver Dis 39 Suppl 1 (2007) S55-60
24. Zignego A.L., Ferri C., Giannelli F., Giannini C., Caini P., Monti M., et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 137 (2002) 571-580
25. Giannelli F., Moscarella S., Giannini C., Caini P., Monti M., Gragnani L., et al. Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood 102 (2003) 1196-1201
26. Radkowski M., Bednarska A., Horban A., Stanczak J., Wilkinson J., Adair D.M., et al. Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. J Gen Virol 85 (2004) 47-59
27. Zignego A.L., Ferri C., Giannini C., Monti M., La Civita L., Careccia G., et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 124 (1996) 31-34
28. Giannini C., Giannelli F., Monti M., Careccia G., Marrocchi M.E., Laffi G., et al. Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease. J Lab Clin Med 134 (1999) 68-73
29. Ansaldi F., Bruzzone B., Salmaso S., Rota M.C., Durando P., Gasparini R., et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 76 (2005) 327-332
30. Kono Y., Hayashida K., Tanaka H., Ishibashi H., and Harada M. High-density lipoprotein binding rate differs greatly between genotypes 1b and 2a/2b of hepatitis C virus. J Med Virol 70 (2003) 42-48
31. Zignego A.L., Macchia D., Monti M., Thiers V., Mazzetti M., Foschi M., et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 15 (1992) 382-386 [see comments]
32. Zignego A.L., Ferri C., Monti M., LaCivita L., Giannini C., Careccia G., et al. Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications. Clin Exp Rheumatol 13 (1995) S33-S37